Skip to main content

REPROCELL Launch New Testing Service for Identification of the Indian (Delta) Covid-19 variant

Yokohama, Japan: We are pleased to announce that REPROCELL will launch a new testing service of identification for Covid-19 variants, including the Indian (Delta), UK, South African, and Brazilian variants. These have all been identified as Variants of Concern (VOC) by the World Health Organization.

The Delta variant is reported to be more contagious than UK one and is widely spreading worldwide. In the UK, the Delta variant is dominant and is thought to have caused a recent surge in new cases.

Considering this, we have launched a new testing service to identify all VOC including the Delta and UK variants. Our new testing system uses PCR screening in combination with SmartAmp technology, thereby covering a wider range of variants. The turnaround time from receiving samples to returning results is less than 24 hours, 7 days a week.

We hope that our high throughput identification service will contribute to the fight against the Covid-19 pandemic.


Corporate news by tag

  1. 3D Cell Culture
  2. Clinical Capabilities
  3. Disease Modeling
  4. Drug Discovery
  5. Genomic Services
  6. GMP
  7. Human Tissue Samples
  8. Human Tissue Testing
  9. Life Sciences
  10. Master Cell Banks
  11. Pharmacology-AI
  12. Precision Medicine
  13. Product Catalog
  14. Regenerative Medicine
  15. Skin Disease
  16. Stem Cells
  17. Volunteer Registry